Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > Studies in Israel already proves it without Dehydratech

<< Previous

Bullboard Posts

Next >>

Comment by InvestABCson Mar 15, 2021 3:19pm

120 Views

Post# 32800525

RE:Studies in Israel already proves it without Dehydratech

just zip your trap DONK.

this idiot shortbashing across multiple boards, what a useless troll !!!!

this is the type of clown with the $1000 portoflio talking it up like he is something other than a basement dwelling peon...

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market